275384-32-2

Upstream product

• 100282-49-3 1,1-dimethylethyl (3-chloro-4-methylphenyl)carbamate 
• 74-88-4 methyl iodide 
• 95-74-9 3-chloro-p-toluidine 
• 24424-99-5 di-tert-butyl dicarbonate 

Downstream Products

• 275384-33-3 4-bromomethyl-N-(tert-butoxycarbonyl)-N-methyl-3-chloroaniline 
• 100282-61-9 1,1-dimethylethyl N-ethyl-N-(3-chloro-4-methylphenyl)carbamate 
• 219767-92-7 methyl 3-(2-chloro-4-(N-methyl-N-(n-pentyl)amino)benzyl)-2-methyl-3H-imidazo[4,5-b]pyridine-5-carboxylate 
• 275384-40-2 4-bromomethyl-N-(tert-butoxycarbonyl)-3-chloro-N-(cyclohexylmethyl)aniline 
• 275383-48-7 methyl 3-(2-chloro-4-(N-ethoxycarbonyl-N-methylamino)benzyl)-2-methyl-3H-imidazo[4,5-b]pyridine-5-carboxylate 
• 275383-44-3 methyl 3-(2-chloro-4-(N-(isopropoxycarbonyl)amino)benzyl)-2-methyl-3H-imidazo[4,5-b]pyridine-5-carboxylate 
• 275384-36-6 methyl 3-(4-(N-(t-butoxycarbonyl)-N-methylamino)-2-chlorobenzyl)-2-methyl-3H-imidazo[4,5-b]pyridine-5-carboxylate 

Relevant academic research and scientific papers

Sulfonamide compounds and uses thereof as medicines

The present invention relates to a sulfonamide compound of the formula (I): wherein each symbol is as defined in the specification, a salt thereof, and a pharmaceutical composition containing same. This compound can be an effective agent for the prophylaxis and treatment of the diseases curable based on a hypoglycemic action, and the diseases curable based on a cGMP-PDE inhibitory action, a smooth muscle relaxing action, a bronchodilating action, a vasodilating action, a smooth muscle cell inhibitory action and an allergy suppressing action.